A 12-week trial suggests that an apple a day may not affect everyone the same way, with baseline gut enterotypes appearing to influence the extent of the microbiome's response to apple fiber and polyphenols.

Study: Apple consumption is associated with obesity- and lipid-related parameters and gut microbiota profiles across enterotypes: 12-week single-blind trial in Japanese adults. Image Credit: Arina P Habich / Shutterstock
In a recent study published in the journal Frontiers in Nutrition, researchers conducted a 12-week single-blind intervention trial to investigate whether baseline gut microbiota structures (“enterotypes”) could significantly modulate microbial and metabolic responses to daily apple consumption. The study comprised 38 Japanese adults whose fecal microbiome sequencing data clustered into three distinct gut enterotypes: Bacteroidaceae (ET1), Ruminococcaceae (ET2), and Prevotellaceae (ET3).
Study findings revealed that while systemic host parameters did not statistically change across the sample cohort, daily apple consumption led to significant enterotype-specific functional changes in microbial outputs. The most notable of these was that the ET1-group participants demonstrated a significant increase in fecal short-chain fatty acids (SCFAs) following the intervention.
These findings imply that host baseline enterotypes may serve as individual-specific functional modifiers of dietary responses, which could inform future precision-nutrition-based clinical nutrition and dietary interventions.
Apple Polyphenols and Enterotype Variability
Modern society is witnessing unprecedented increases in the prevalence of chronic metabolic conditions, such as obesity and cardiovascular diseases (CVDs), driving intensified research into the protective roles of biomolecules (e.g., polyphenols and dietary fibers) that are known to mitigate these conditions.
Decades of nutritional research have established apples (Malus domestica L.) as a rich dietary source of these compounds (rich in pectin and flavan-3-ols), supporting their roles in modulating metabolic health. However, while emergent preclinical research has demonstrated that apple procyanidins can modulate the Firmicutes/Bacteroidetes ratio and prevent weight gain in murine models, data from human clinical trials are less consistent.
Scientists attribute these discrepancies to the substantial inter-individual variability observed in the human gut microbiome and have recently proposed the concept of "enterotypes" (analytical clusters based on dominant genera) as a framework for measuring and understanding these variations.
Unfortunately, enterotypes are often viewed as static biomarkers rather than dynamic "response modifiers," and previous research has not sufficiently investigated whether enterotypes can predict differential responses to specific food interventions.
12-Week Apple Trial Design
The present study aims to address these limitations by testing the hypothesis that baseline enterotypes could influence the metabolic and functional outcomes of an “apple a day” regimen. The study’s methodology leveraged a 12-week, single-blind (no control group) intervention trial involving 38 Japanese adults (24 males, 14 females; age = 41-63 years) with a mean body mass index (BMI) of 23.5 kg/m2.
Each participant was required to consume one fresh "Fuji" apple (peeled and cored) daily. Nutritional analyses of these fruits (~300g each) revealed that these apples comprised ~176.7 mg of procyanidins (total polyphenols = ~240.6 mg) and ~4.0g of total dietary fiber.
Participants’ experimental data collection occurred at baseline and at weeks 4, 8, and 12, and included anthropometric measurements (e.g., BMI), blood chemistry (e.g., glucose and lipids), and fecal samples used for microbial community analyses and short-chain fatty acid (SCFA) measurement (16S rRNA gene sequencing of the V3-V4 region).
Subsequently, Jensen-Shannon divergence (JSD) and partitioning around medoid (PAM) clustering were used to classify participants into enterotypes (at the family level). Statistical analyses primarily leveraged microbiome multivariable association with linear models 3 (MaAsLin 3) to identify longitudinal associations between derived microbial features and participant-specific metabolic status.
Enterotype-Specific SCFA Findings
Gene sequencing analyses identified three baseline enterotypes: ET1 (Bacteroidaceae, n = 14), ET2 (Ruminococcaceae, n = 18), and ET3 (Prevotellaceae, n = 6). However, subsequent evaluation of host-level systemic parameters (e.g., BMI, fasting glucose, and lipid profiles) found no statistically significant changes across the entire group.
Further analysis revealed substantial enterotype-specific functional responses: the ET1 cohort showed significant within-group increases in fecal SCFA levels (acetate, propionate, and butyrate; p < 0.05 or q < 0.01 for various comparisons) following apple consumption, whereas ET2 and ET3 did not show significant changes.
MaAsLin 3 analysis corroborated these findings, revealing significant interactions between five microbial genera (Bifidobacterium, Prevotella, Dialister, Anaerostipes, and Lachnospira) and participant-specific metabolic status (obesity and hyperlipidemia).
However, these functional microbial shifts occurred without observable changes in the relative abundance of the specific bacterial populations known to be responsible for SCFA production (e.g., Bifidobacterium or Lachnospira). Together, these findings imply that the primary impact of apple-derived polyphenols and fiber is on the gut's metabolic output rather than immediate, measurable changes in host lipid and glucose profiles.
Precision Nutrition Implications of Apple Intake
The present study demonstrates that the metabolic responses to apple consumption may be shaped by an individual's baseline gut structure. The significant increase in SCFAs within the Bacteroidaceae-dominant enterotype suggests that these individuals may derive more immediate functional benefits from apple fiber fermentation than their ET2 and ET3 counterparts.
While the study is notably limited by its single-arm design (no control group) and the relatively small sample size of the ET3 subgroup, these findings establish that enterotypes act as "response modifiers," in which dietary effectiveness depends on individual-specific pre-existing microbial ecosystem.